Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 410 results for "nexium"

Ranbaxy may lose exclusivity on Nexium generic

Ranbaxy was expected to launch its low-cost version in May, when the Nexium patent expired. Photo: Pradeep Gaur/Mint The Indian drug maker may lose the six-month market exclusivity for the Nexium copy in the US as there is pressure mounting on the ... Livemint.com, 2 days ago
Another Nexium patent case closed Pharma In Focus, 1 month ago

7 images for nexium

Impact Lab, 1 week ago
FDA News, 2 weeks ago
Weston Forum, 1 week ago
Hartford Business Journal, 2 weeks ago
SearchBug, 1 month ago
FDA News, 1 month ago
Rocky Mount Telegram, 2 months ago
Sify

Ranbaxy faces multi-pronged battle on Nexium in US

is facing increasing pressure from different states in the US, rival generic drugmakers, consumer groups, drug retailers and wholesalers to either immediately bring to market the first generic version of British-Swedish innovator AstraZeneca's blockbuster ...
 Economic Times1 week ago Ranbaxy gets FDA approval for Novartis's Diovan generic  The Financial Chronicle2 months ago India's Ranbaxy gains; U.S. drug regulator approves generic version of Novartis drug  Sify2 months ago Ranbaxy up; nod to generic version of Novartis drug  Sify2 months ago

Connecticut AG George Jepsen to USFDA: Pull up Ranbaxy for failing to launch drug Nexium

NEW DELHI: Ranbaxy Laboratories is facing increasing pressure from different states in the US, rival generic drugmakers, consumer groups, drug retailers and wholesalers to either immediately bring to market the first generic version of ...
 Economic Times1 week ago

Human medicines European public assessment report (EPAR): Nexium Control, esomeprazole, Revision: 4, Authorised

This is a summary of the European public assessment report (EPAR) for Nexium Control. It explains how the European Medicines Agency assessed the medicine to recommend its authorisation in the European Union (EU) and its conditions of use. It is not ...
 European Medicines Agency1 month ago

AstraZeneca Raises Forecast as Nexium Fee Boosts Profit

AstraZeneca Plc (AZN), raised its forecast after reporting quarterly profit that beat analyst estimates, helped by a $200 million payment from one-time suitor Pfizer Inc. for rights to an over-the-counter version of the Nexium heartburn treatment. ...
 BusinessWeek1 month ago

USFDA boost for Ranbaxy; see akin deal for Nexium: Dandekar

After a long stretch of regulatory hassles, Vikas Dandekar of PharmAsiaNews.Com believes the worst is behind for the pharma major with this USFDA boost, a USD 3.4 billion opportunity.
 Money Control2 months ago India's drug industry to touch $48 billion by 2018  India Brand Equity Foundation3 days ago Sun Pharma to firm up steps to boost Ranbaxy drug sales  Economic Times1 week ago Ranbaxy stock up 50% post deal with Sun Pharma  Economic Times1 month ago

AG Jepsen to FDA: End Bottleneck Preventing Generic Nexium from Entering the Market

Cites evidence that drug-maker Ranbaxy is delaying generic, hurting consumers by inflating cost of second highest-selling drug in the U.S. In comments to a Citizen Petition filed with the Food and Drug Administration (FDA) today, Attorney General ...
 Noodls2 weeks ago RANBAXY LABORATORIES : AG Jepsen to FDA: End Bottleneck Preventing Generic Nexium from Entering the Market  4 Traders2 weeks ago
Securities Technology Monitor

Rascal Flatts Joins the Thousands of People Who Choose Nexium® 24HR Every Day for Their Frequent Heartburn

Join Rascal Flatts Today and Choose Nexium 24HR - Satisfaction Guaranteed NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE:PFE) announced today that the members of Rascal Flatts, the most-awarded country music band of the past decade, are among the ...
 Nasdaq1 month ago INTERVIEW: Rascal Flatts on finding their new EDM-tinged sound  She Knows1 month ago AstraZeneca PLC Touts 2nd Quarter Results After Fending Off Pfizer Inc., CEO And Investors Rejoice  BioSpace1 month ago Pfizer Releases 2Q 2014 Results  Individual.com1 month ago
[x]  

Pfizer's OTC Nexium not far away

 Pharma In Focus5 days ago
FDA News

FDA faces pressure to green-light generic versions of AZ's pricey Nexium

Connecticut Attorney General George Jepsen Back in 2008, Indian generics maker Ranbaxy made a deal with AstraZeneca ($AZN) to launch its Nexium copycat in May of this year. So why are Americans still unable to buy cheap versions of the blockbuster ...
 FiercePharma1 week ago AstraZeneca Sues Zydus Cadila Over Generic Nexium Bid  FDA News1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less